Jyong Biotech
(NASDAQ) MENS
Jyong Biotech Financials at a Glance
Market Cap
$181.87M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.25M
EPS (TTM)
$-0.04
P/E Ratio
-60.79
Dividend
$0.00
Beta (Volatility)
6.62 (High)
Dividend
$0.00
Beta (Volatility)
6.62 (High)
Price
$2.49
Volume
124,636.301
Open
$2.48
Price
$2.49
Volume
124,636.301
Open
$2.48
Previous Close
$2.47
Daily Range
$2.41 - $2.68
52-Week Range
$1.43 - $67.00
Dividend
$0.00
Beta (Volatility)
6.62 (High)
Price
$2.49
Volume
124,636.301
Open
$2.48
Previous Close
$2.47
Daily Range
$2.41 - $2.68
52-Week Range
$1.43 - $67.00
MENS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jyong Biotech
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
Fu Feng Kuo, MBA
Headquarters
New Taipei City, 221, TW
MENS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-8%
Return on Assets
-3%
Earnings Yield
-1.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$181.87M
Shares Outstanding
74.23M
Volume
124.64K
Short Interest
0.00%
Avg. Volume
335.95K
Financials (TTM)
Gross Profit
$120.00K
Operating Income
$2.06M
EBITDA
$1.86M
Operating Cash Flow
$3.62M
Capital Expenditure
$0.00
Free Cash Flow
$3.62M
Cash & ST Invst.
$98.00K
Total Debt
$18.14M
Jyong Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$181.87M
N/A
Market Cap/Employee
$5.87M
N/A
Employees
31
N/A
Net Income
$1.25M
-188738.6%
EBITDA
$835.00K
-187751.5%
Quarterly Fundamentals
Net Cash
$18.18M
-5.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$12.28M
+26.0%
Short Term Debt
$22.92M
+200.7%
Return on Assets
-3.33%
N/A
Return on Invested Capital
-8.07%
N/A
Free Cash Flow
$425.50
+35.0%
Operating Cash Flow
$425.50
+35.0%